Skip to main content
Advertisement
Advertisement

VANI

VANI logo

Vivani Medical, Inc. Common Stock (DE)

1.23
USD
Sponsored
-0.04
-3.15%
Sep 23, 15:56 UTC -4
Closed
exchange

After-Market

1.26

+0.03
+2.68%

VANI Earnings Reports

Positive Surprise Ratio

VANI beat 17 of 30 last estimates.

57%

Next Report

Date of Next Report
Nov 11, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$0.08
Implied change from Q2 26 (Revenue/ EPS)
--
/
+14.29%
Implied change from Q3 25 (Revenue/ EPS)
--
/
-27.27%

Vivani Medical, Inc. Common Stock (DE) earnings per share and revenue

On Aug 13, 2026, VANI reported earnings of -0.07 USD per share (EPS) for Q2 26, beating the estimate of -0.08 USD, resulting in a 17.65% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.48% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.08 USD, with revenue projected to reach -- USD, implying an increase of 14.29% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Champions Oncology, Inc.
Report Date
Sep 10, 2026 For Q1 27
Estimate
-$0.01
Actual
-$0.03
Surprise
-194.12%
logo
PharmaCyte Biotech, Inc. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-
Actual
-$0.54
Surprise
-
FAQ
For Q2 2026, Vivani Medical, Inc. Common Stock (DE) reported EPS of -$0.07, beating estimates by 17.65%, and revenue of $0.00, 0% as expectations.
The stock price moved up 4.48%, changed from $1.34 before the earnings release to $1.40 the day after.
The next earning report is scheduled for Nov 11, 2026.
Based on 3 analysts, Vivani Medical, Inc. Common Stock (DE) is expected to report EPS of -$0.08 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement